精神分裂症是一组严重高致残性精神疾病,临床症状复杂多样,主要包括阳性症状、阴性症状及认知功能障碍。在精神分裂症急性发作期,患者可出现冲动、攻击等风险行为,对个人、家庭及社会的危害巨大。抗精神病药物是治疗精神分裂症的首选。但患者多因用药依从性不佳而致病情反复迁延,增加患者、家庭及社会的负担。2025年12月24日,绿叶制药发布公告,公司已与恩华药业签署合作协议,授予后者三款抗精神病药长效针剂产品在...
Source Link精神分裂症是一组严重高致残性精神疾病,临床症状复杂多样,主要包括阳性症状、阴性症状及认知功能障碍。在精神分裂症急性发作期,患者可出现冲动、攻击等风险行为,对个人、家庭及社会的危害巨大。抗精神病药物是治疗精神分裂症的首选。但患者多因用药依从性不佳而致病情反复迁延,增加患者、家庭及社会的负担。2025年12月24日,绿叶制药发布公告,公司已与恩华药业签署合作协议,授予后者三款抗精神病药长效针剂产品在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.